Cameron Turtle
Chief Executive Officer at Spyre Therapeutics; Director at Oruka Therapeutics. Based in Waltham, Massachusetts.
- Rank
- 2434th of 14,644
- Companies held
- 2
- Largest holding
- SYRE, 98.7% of total
- Latest SEC filing
- Oct 1, 2026
What the $53.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Spyre Therapeutics SYRE Common Stock | Directly | 537,540 | $98.05 | $52.7M | 98.7% | Form 4, Oct 1, 2026 |
| Oruka Therapeutics ORKA Common Stock | Through Turtle Family Trust | 7,103 split-adjusted | $98.39 | $699K | 1.3% | Form 3, Aug 29, 2024 |
Share counts are the amounts Cameron Turtle reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Sold | SYRE | 600 | $89.14 | $53K | View |
| Oct 1, 2026 | Sold | SYRE | 2,683 | $90.10 | $242K | View |
| Oct 1, 2026 | Sold | SYRE | 2,638 | $91.49 | $241K | View |
| Oct 1, 2026 | Sold | SYRE | 3,989 | $92.31 | $368K | View |
| Oct 1, 2026 | Sold | SYRE | 4,990 | $93.37 | $466K | View |
| Oct 1, 2026 | Sold | SYRE | 100 | $93.91 | $9K | View |
| Sep 1, 2026 | Sold | SYRE | 8,400 | $87.15 | $732K | View |
| Sep 1, 2026 | Sold | SYRE | 2,500 | $86.36 | $216K | View |
| Sep 1, 2026 | Sold | SYRE | 400 | $89.07 | $36K | View |
| Sep 1, 2026 | Sold | SYRE | 3,700 | $88.06 | $326K | View |
| Aug 3, 2026 | Sold | SYRE | 800 | $93.97 | $75K | View |
| Aug 3, 2026 | Sold | SYRE | 7,157 | $95.10 | $681K | View |
| Aug 3, 2026 | Sold | SYRE | 5,635 | $95.93 | $541K | View |
| Aug 3, 2026 | Sold | SYRE | 1,392 | $96.82 | $135K | View |
| Aug 3, 2026 | Sold | SYRE | 16 | $97.46 | $2K | View |
| Jul 1, 2026 | Sold | SYRE | 4,234 | $88.12 | $373K | View |
| Jul 1, 2026 | Sold | SYRE | 590 | $88.91 | $52K | View |
| Jul 1, 2026 | Sold | SYRE | 10,176 | $87.44 | $890K | View |
| Jun 1, 2026 | Sold | SYRE | 3,294 | $71.38 | $235K | View |
| Jun 1, 2026 | Sold | SYRE | 8,149 | $70.50 | $575K | View |
| Jun 1, 2026 | Sold | SYRE | 3,557 | $69.40 | $247K | View |
| May 1, 2026 | Sold | SYRE | 3,100 | $73.14 | $227K | View |
| May 1, 2026 | Sold | SYRE | 1,000 | $71.76 | $72K | View |
| May 1, 2026 | Sold | SYRE | 3,600 | $70.77 | $255K | View |
| May 1, 2026 | Sold | SYRE | 5,300 | $69.54 | $369K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2431 | Corie S. Barry CEO, Best Buy Co.. Ann Arbor, MI | $53.4M |
| 2432 | Ganesh Moorthy PRESIDENT AND CEO, Microchip Technology. Malta, NY | $53.4M |
| 2433 | Robert Soderbery EVP & GM, Flash Business, Western Digital. Milwaukee, WI | $53.4M |
| 2434 | Cameron Turtle Chief Executive Officer, Spyre Therapeutics. Waltham, MA | $53.4M |
| 2435 | Paul M. Donofrio Vice Chair, Bank of America. Charlotte, NC | $53.4M |
| 2436 | W. Blake Baird CHAIRMAN AND CEO, Terreno Realty. Bellevue, WA | $53.4M |
| 2437 | John B. Wood Chairman and CEO, Telos. Ashburn, VA | $53.4M |
Other Spyre Therapeutics insiders
All SYRE insiders- Scott L. Burrows$7.8MChief Financial Officer. #9219 overall
- Michael Thomas Henderson$6.7MDirector. #11797 overall
- Marcio Souza$353KDirector. #5510 overall
Questions
How much stock does Cameron Turtle own?
Cameron Turtle holds $53,404,637 in listed stock based on SEC filings and current prices, mostly Spyre Therapeutics (SYRE). That ranks 2434th on the Stock Rich List.
Is this Cameron Turtle's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Cameron Turtle last buy or sell stock?
The most recent open-market trade on file is a sale of 600 SYRE shares on Oct 1, 2026 at $89.14.